Nervgen PharmaNGEN
13F holders, Q1 2024 (March 31)1holders
$1.47avg. 13F price*
At the end of Q1 2024, 1 institutions reported holding Nervgen Pharma Corp. (NGEN) in their 13F filings. The largest holder was FNY Investment Advisers, LLC ($5K).
- Company
- Nervgen Pharma Corp.
- CUSIP
- 64082X203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 1 holders
| FNY Investment Advisers, LLC | 0.00% | No change | 3,400 | $5K |
"% of holder's portfolio" is NGEN's weight in each manager's 13F, not the share of Nervgen Pharma Corp. the manager owns.